ACTIOGEN ACNE DOTS TREATMENT- acne treatment patch

Actiogen Acne Dots Treatment by

Drug Labeling and Warnings

Actiogen Acne Dots Treatment by is a Otc medication manufactured, distributed, or labeled by Actiogen Corp. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredients

Salicylic Acid 2%

Purpose

Acne Treatment

Use

For the treatment of acne

DOSAGE & ADMINISTRATION

Warnings

For external use only

When Using This Product

Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin.  If this occurs, only one medication should be used unless directed by a doctor

Stop Using This Product 

Discontinue use if you notice an redness, burning, or other forms of irritation

Do Not Use

Do not use on broken skin or open wounds

Consult a physician

Consult your physician in case of adverse reaction

Keep Out of Reach of Children

Keep away from children

Other Information

Store in a cool dry place.

Inactive Ingredients

Acrylic adhesive, kollidon, 1,2 Propylene Glycol, Zinc Oxide

PRINCIPAL DISPLAY PANEL

Front of Box

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

ACTIOGEN ACNE DOTS TREATMENT 
acne treatment patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69186-001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	2 mg  in 100 mg

Inactive Ingredients
Ingredient Name	Strength
ACRYLIC ACID (UNII: J94PBK7X8S)	96 mg  in 100 mg
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)	1 mg  in 100 mg
ZINC OXIDE (UNII: SOI2LOH54Z)	1 mg  in 100 mg

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69186-001-10	10 in 1 BOX	08/01/2014
1		2 mg in 1 PACKAGE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part333D	08/01/2014

Labeler - Actiogen Corp (967358057)